Novel technique may improve detection of aggressive prostate cancer
A molecular imaging biomarker detects fast-growing prostate cancer (PCa) on positron-emission tomography-computed tomography (PET-CT) and differentiates it from benign lesions, a small study finds.
The study employed the radiotracer 18F-DCFBC targeting the prostate-specific membrane antigen (PSMA), which is associated with PCa aggressiveness. If PSMA-based radiotracers continue to prove reliable, combining PET-CT results with magnetic resonance imaging (MRI) can improve PCa detection. Read more.